InsidersTradesSigma
동성제약: management transactions · South Korea · DART (FSS)
DART:company-d02227KR·DART (FSS)Mcap 105.9Bn€
Browse the full directors' dealings record of 동성제약, a listed equity based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Market capitalisation: €105.9bn. The latest transaction was reported on 15 April 2026 — Purchase. Among the most active insiders: 유암코제약산업제1호기업재무안정사모투자. All data is openly available.
6
Insider Decl.
0
Thresholds
€96m
5 ops.
Buy Volume
€4m
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
973.00 €
Income statement
Revenue87.17 Bn€
Gross profit37.11 Bn€43% margin
Net income−25.74 Bn€-29.5% margin
Balance sheet & cash
Market cap105.87 Bn€
Total debt64.13 Bn€
Free Cash Flow−14.20 Bn€
Last declaration on 15 April 2026
Declarations6 total
Executives●Purchase12DART
€18m31,500,000 shares@ €0.580.017% mcap100.0% of flow
ShareKRX
DART:20260415000145·
Ideal exit: 4 Jan 2027 (T+270)
Executives●Purchase2DART
€28m50,000,000 shares
KRX
DART:20260415000133·
Ideal exit: 10 Jan 2027 (T+270)
Executives●Purchase10DART
€5m8,500,000 shares@ €0.580.0047% mcap100.0% of flow
ShareKRX
DART:20260415000150·
Ideal exit: 4 Jan 2027 (T+270)
Executives●Purchase2DART
€39m70,000,000 shares
KRX
DART:20260406003017·
Ideal exit: 1 Jan 2027 (T+270)
6 of 6 declarations